Clinical Trials Browser

Phase 3 × Aprepitant × Plasma cell × Clear all

NCT02939287 2024-10-22

Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan

Phase 3 Completed

52 enrolled 11 charts

Nausea, Vomiting, Neoplasms, Plasma Cell

NCT00571168 2010-01-12

EmNa

Phase 3 Unknown

Multiple Myeloma, Vomiting